Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3.

Kristian ReichL IversenLluis L PuigJ LambertUlrich MrowietzK Kaplan SadayR B Warren

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)

Brodalumab treatment was well tolerated and resulted in high levels of skin clearance that were rapidly achieved and maintained through Week 120, supporting its long-term efficacy and safety profile.

Keyphrases

coronary artery disease
early onset
high intensity
wound healing
combination therapy
replacement therapy